Company intelligence / Profile preview

Leal Health

New York, New York, USAleal.health ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Leal Health has developed an AI-powered digital health platform that provides cancer patients with a single point of access to all relevant FDA-approved treatments, standard-of-care options, and clinical trials. The system leverages real-world data from millions of patient journeys to deliver highly personalized treatment recommendations. As of mid 2024, the company has facilitated over 3 million treatment matches for cancer patients worldwide[1][3][7]. The addition of GenAI capabilities further enhances the ability to predict optimal future treatments based on similar patient outcomes[5].

Therapeutic areas: Oncology
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Advocacy groupsPharmaceutical companies

Beyond the preview

Go deeper on Leal Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leal Health.

Explore the full profile